Literature DB >> 3575370

Potentiation of odor by taste and odor aversions in rats are regulated by cholinergic activity of dorsal hippocampus.

F Bermúdez-Rattoni, K L Coburn, J Fernández, A F Chávez, J Garcia.   

Abstract

Limbic cholinergic activity is critically involved in the retention of learned aversions tasks. The purpose of these experiments was to assess the role of cholinergic mechanisms of the dorsal hippocampus in the acquisition of both odor and potentiated odor aversions through taste aversion. Cholinergic activity was increased by physostigmine (Phys). When Phys was applied before the presentation of an odor-taste compound during acquisition, the potentiation of odor-aversion was disrupted, while taste aversion was left intact. When hippocampal cholinergic activity was reduced with the muscarinic antagonist scopolamine (Scop), enhancement of potentiated odor aversion was observed, again with no effect on taste aversion. Moreover, when Phys was applied before an odor alone it also disrupted odor avoidance in two different odor tests conditioning situations, i.e., odor was followed immediately by lithium chloride or foot shock. Neither Scop nor Phys had any effect on taste or potential odor aversions when applied to fronto-parietal cortex. These results suggest that cholinergic activity of the hippocampus is involved in the acquisition of odor aversion conditioning.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3575370     DOI: 10.1016/0091-3057(87)90165-1

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  3 in total

1.  Comparison of the sensitivity of C57BL/6J and AKR/J mice to airborne molecules of isovaleric acid and amyl acetate.

Authors:  L Pourtier; G Sicard
Journal:  Behav Genet       Date:  1990-07       Impact factor: 2.805

2.  Fos and Egr1 expression in the rat brain in response to olfactory cue after taste-potentiated odor aversion retrieval.

Authors:  David Dardou; Frédérique Datiche; Martine Cattarelli
Journal:  Learn Mem       Date:  2006-03-17       Impact factor: 2.460

3.  Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor systems.

Authors:  Soheil Keihan Falsafi; Alev Deli; Harald Höger; Arnold Pollak; Gert Lubec
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.